Literature DB >> 8039813

T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.

I Kramnik1, D Radzioch, E Skamene.   

Abstract

The Bcg gene has been shown to control natural resistance of mice to intravenous infection with low doses of Mycobacterium bovis (bacillus Calmette-Guérin; BCG). In the present study, we evaluated the impact of the Bcg gene on the development of T-cell reactivity during the early stages of infection. Congenic strains of mice, bearing 'r' and 's' alleles of the Bcg gene on B10.A and BALB/c backgrounds, were studied at different time-points for 2 weeks after infection. The in vitro proliferative response of spleen cells, induced by mycobacteria or concanavalin A, was depressed in the Bcgs mice compared to the Bcgr congenic mice 14 days after infection with 10(5) colony-forming units (CFU) of BCG. Polymerase chain reaction (PCR)-based methodology was used to compare the level of lymphokine gene expression in the spleens of infected congenic mice both ex vivo and after in vitro stimulation. In both cases, preferential expression of interferon-gamma (IFN-gamma), lymphotoxin, interleukin-2 (IL-2) and IL-2 receptor genes was observed. The lymphokine gene expression profiles indicated that T lymphocytes activated in the course of the BCG infection preferentially expressed the T-helper 1-specific pattern, irrespective of the allele of the Bcg gene. We showed that this bias in T-cell differentiation could not be attributed to either down-regulation of IL-4 gene expression or modulation of the macrophage co-stimulatory activity by live M. bovis BCG. We conclude that the mechanism of phenotypic expression of the Bcg gene resides in the differential ability of macrophages to be activated by lymphokines produced by protective T cells, rather than in the lack of these lymphokines in susceptible animals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039813      PMCID: PMC1422372     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Assessment of lymphokine profiles in activated lymphocytes by semiquantitative PCR.

Authors:  I Kramnik; E Skamene; D Radzioch
Journal:  J Immunol Methods       Date:  1993-06-18       Impact factor: 2.303

2.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

Authors:  P Salgame; J S Abrams; C Clayberger; H Goldstein; J Convit; R L Modlin; B R Bloom
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

3.  A BALB/c congenic strain of mice that carries a genetic locus (Ityr) controlling resistance to intracellular parasites.

Authors:  M Potter; A D O'Brien; E Skamene; P Gros; A Forget; P A Kongshavn; J S Wax
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

4.  Immune response to atypical mycobacteria: immunocompetence of heavily infected mice measured in vivo fails to substantiate immunosuppression data obtained in vitro.

Authors:  I M Orme; F M Collins
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

5.  Genetic regulation of resistance to intracellular pathogens.

Authors:  E Skamene; P Gros; A Forget; P A Kongshavn; C St Charles; B A Taylor
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

6.  Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice.

Authors:  K Huygen; D Abramowicz; P Vandenbussche; F Jacobs; J De Bruyn; A Kentos; A Drowart; J P Van Vooren; M Goldman
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

7.  Influence of H-2 genes on growth of Mycobacterium tuberculosis in the lungs of chronically infected mice.

Authors:  S Brett; J M Orrell; J Swanson Beck; J Ivanyi
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

8.  Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG).

Authors:  J L Stach; P Gros; A Forget; E Skamene
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

9.  Recombinant inbred mouse strains derived from A/J and C57BL/6J: a tool for the study of genetic mechanisms in host resistance to infection and malignancy.

Authors:  M N Nesbitt; E Skamene
Journal:  J Leukoc Biol       Date:  1984-09       Impact factor: 4.962

10.  Pleiotropic effects of the Bcg gene. I. Antigen presentation in genetically susceptible and resistant congenic mouse strains.

Authors:  M Denis; A Forget; M Pelletier; E Skamene
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

View more
  16 in total

1.  Mycobacterium bovis BCG-infected mice are more susceptible to staphylococcal enterotoxin B-mediated toxic shock than uninfected mice despite reduced in vitro splenocyte responses to superantigens.

Authors:  João A Pedras-Vasconcelos; Yvan Chapdelaine; Renu Dudani; Henk van Faassen; Dean K Smith; Subash Sad
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Capacity of murine T cells to retain long-term responsiveness to mycobacterial antigens is controlled by the H-2 complex.

Authors:  A V Pichugin; S V Khaidukov; A M Moroz; A S Apt
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 3.  Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study.

Authors:  J M Blackwell; G F Black; C S Peacock; E N Miller; D Sibthorpe; D Gnananandha; J J Shaw; F Silveira; Z Lins-Lainson; F Ramos; A Collins; M A Shaw
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

4.  Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation.

Authors:  T Lang; E Prina; D Sibthorpe; J M Blackwell
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Acquired resistance but not innate resistance to Mycobacterium bovis bacillus Calmette-Guérin is compromised by interleukin-12 ablation.

Authors:  L Thompson-Snipes; E Skamene; D Radzioch
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

6.  Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: establishment of latency and reactivation.

Authors:  D H Brown; B A Miles; B S Zwilling
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  Slc11a1 limits intracellular growth of Salmonella enterica sv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition.

Authors:  Manfred Nairz; Gernot Fritsche; Marie-Laure V Crouch; Howard C Barton; Ferric C Fang; Günter Weiss
Journal:  Cell Microbiol       Date:  2009-06-02       Impact factor: 3.715

8.  Immune responsiveness in Mycobacterium avium-infected mice: changes in the proportion of T cell subsets and antibody production during the course of infection.

Authors:  D L Xu; Y Goto; K K Amoako; T Nagatomo; K Uchida; T Shinjo
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

9.  Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity.

Authors:  R Nadler; Y Luo; W Zhao; J K Ritchey; J C Austin; M B Cohen; M A O'Donnell; T L Ratliff
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

10.  Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function.

Authors:  Carmel B Stober; Sven Brode; Jacqueline K White; Jean-François Popoff; Jenefer M Blackwell
Journal:  Infect Immun       Date:  2007-07-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.